Viral safety of oral poliovirus vaccine (OPV)

  • Email
  • Help
Current version

Position paper

Reference numberCPMP/BWP/972/98
KeywordsOral poliovirus vaccine (OPV), safety, monkey kidney cell, cell substrates, simian virus 40 (SV4), simian immunodeficiency virus (SIV), adventitious agent, inactivated polivirus vaccine

This document gives consideration to the safety aspects of oral polio vaccines (OPV). It covers the possibility for introducing PCR testing of OPV for viral contamination.

EMA has not updated this document as all relevant information is included in the applicable European Pharmacopoeia monographs.

Related content

How helpful is this page?

Average rating:

 Based on 31 ratings

Add your rating:

See all ratings
7 ratings
6 ratings
6 ratings
6 ratings
6 ratings

Tell us more